Journal article

Pharmacological validation of targets regulating CD14 during macrophage differentiation

G Jimenez-Duran, R Luque-Martin, M Patel, E Koppe, S Bernard, C Sharp, N Buchan, C Rea, MPJ de Winther, N Turan, D Angell, CA Wells, R Cousins, PK Mander, SL Masters

Ebiomedicine | ELSEVIER | Published : 2020

Open access

Abstract

The signalling receptor for LPS, CD14, is a key marker of, and facilitator for, pro-inflammatory macrophage function. Pro-inflammatory macrophage differentiation remains a process facilitating a broad array of disease pathologies, and has recently emerged as a potential target against cytokine storm in COVID19. Here, we perform a whole-genome CRISPR screen to identify essential nodes regulating CD14 expression in myeloid cells, using the differentiation of THP-1 cells as a starting point. This strategy uncovers many known pathways required for CD14 expression and regulating macrophage differentiation while additionally providing a list of novel targets either promoting or limiting this proce..

View full abstract

University of Melbourne Researchers